Q1 2026 · 13F-HR
AIHC Capital Management Ltdholdings as filed
Filed 2026-05-08 · accession 0001172661-26-001629
$119.7M
Reported value
5
Positions
2026-03-31
Period end
The Brief · AIHC Capital Management Ltd · Q1 2026
AI · grounded in 13F
AIHC Capital Management Ltd established a new position in ORIC valued at $31.16M. The fund closed its positions in PTGX, reducing exposure by $16.58M, and AVBP, reducing exposure by $12.97M. Additionally, the fund increased its stake in NBP by 446.63% while trimming shares of COGT by 48.60%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $80.6M | 67.4% | 828,974 | Common | SOLE |
| 68622P109 | ORIC | ORIC PHARMACEUTICALS INC | $31.2M | 26.0% | 2,459,551 | Common | SOLE |
| 44975P103 | NBP | NOVABRIDGE BIOSCIENCES | $5.6M | 4.65% | 2,262,933 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $2.0M | 1.65% | 51,402 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $342,600 | 0.29% | 30,265 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.